Fredrik Melander
Impact in
- Molecular Biology top 2%
- DNA Repair Mechanisms
- Genomics and Chromatin Dynamics
- Ubiquitin and proteasome pathways
- CRISPR and Genetic Engineering
- Oncology top 2%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
Papers in
-
- DNA Repair Mechanisms 5
- Genomics and Chromatin Dynamics 4
- Biomaterials 10
- Nanoparticle-Based Drug Delivery 10
- Co-authors
- Jiří Bártek (6 shared papers)Simon Bekker‐Jensen (5 shared papers)Claudia Lukas (4 shared papers)Niels Mailand (2 shared papers)Thomas L. Andresen (23 shared papers)Michael B. Kastan (1 shared paper)Risa Kitagawa (1 shared paper)Jacob Falck (2 shared papers)
- Journals
- Journal of Controlled Release (3 papers)The Journal of Cell Biology (3 papers)Advanced Healthcare Materials (2 papers)Cancer Research (2 papers)ACS Nano (2 papers)
- Partner nations
- DenmarkSwedenUnited States
In The Last Decade
Fredrik Melander
35 papers receiving 3.3k citations
Fredrik Melander's Hit Papers
Peers
Comparison fields: 5 of 112
- Molecular Biology 2.6k
- Oncology 920
- Cancer Research 456
- Biomaterials 349
- Cell Biology 297
Countries citing papers authored by Fredrik Melander
This map shows the geographic impact of Fredrik Melander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fredrik Melander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fredrik Melander more than expected).
Fields of papers citing papers by Fredrik Melander
This network shows the impact of papers produced by Fredrik Melander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fredrik Melander. The network helps show where Fredrik Melander may publish in the future.
Co-authors
The 25 scholars most cited alongside Fredrik Melander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | RNF8 Ubiquitylates Histones at DNA Double-Strand Breaks and Promotes Assembly of Repair Proteins Hit paper breakdown → | 2007 | 928 |
| 2 | 2006 | 497 | |
| 3 | 2004 | 314 | |
| 4 | 2005 | 233 | |
| 5 | 2017 | 211 | |
| 6 | 2008 | 183 | |
| 7 | 2004 | 182 | |
| 8 | 2019 | 129 | |
| 9 | 2018 | 121 | |
| 10 | 2009 | 73 | |
| 11 | 2009 | 57 | |
| 12 | 2020 | 52 | |
| 13 | 2018 | 52 | |
| 14 | 2017 | 43 | |
| 15 | 2003 | 40 | |
| 16 | 2001 | 36 | |
| 17 | 2015 | 29 | |
| 18 | 2018 | 27 | |
| 19 | 2000 | 23 | |
| 20 | 2007 | 21 |
About Fredrik Melander
Fredrik Melander is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Immunology and Allergy and Immunology, having authored 36 papers that have together received 3.4k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (10 papers), Cell Adhesion Molecules Research (6 papers), Nanoplatforms for cancer theranostics (6 papers), DNA Repair Mechanisms (5 papers), Genomics and Chromatin Dynamics (4 papers), Barrier Structure and Function Studies (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Molecular Biology (2.6k citations), Oncology (920 citations), Cancer Research (456 citations), Biomaterials (349 citations) and Cell Biology (297 citations). Fredrik Melander has collaborated with scholars based in Denmark, Sweden and United States. Frequent co-authors include Jiří Bártek, Simon Bekker‐Jensen, Claudia Lukas, Niels Mailand, Thomas L. Andresen, Michael B. Kastan, Risa Kitagawa, Jacob Falck, Tommy Andersson and Paul J. Kempen. Their work appears in journals such as Journal of Controlled Release, The Journal of Cell Biology, Advanced Healthcare Materials, Cancer Research and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.